⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 7, 2024Diabetes Obesity and MetabolismOpen Access

A randomized, double‐blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD‐JPN)

Tomoaki Morioka Masakazu Takeuchi Akichika Ozeki Masanori Emoto

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the efficacy and safety of dulaglutide 1.5 mg versus dulaglutide 0.75 mg in Japanese participants with type 2 diabetes (T2D).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Morioka et al. (2024) studied this question.

synapsesocial.com/papers/68e6b4c2b6db643587635771 https://doi.org/10.1111/dom.15644

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled TrialRCT · 2019 · 11 citations
2Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once‐weekly dulaglutide <scp>AWARD</scp> programmeOriginal Research · 2015 · 17 citations
3Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 DiabetesOriginal Research · 2025 · 6 citations
4Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)RCT · 2014 · 394 citations
5Comparison between liraglutide and dulaglutide on the incidence or progression of eye and kidney complicationsOriginal Research · 2026 · 1 citations

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index2022
Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise2014
Comparative efficacy and safety of weekly dulaglutide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials2024
Digital Food Purchase Signatures and Their Response to GLP‐1‐Based Treatment in People With ObesityDiabetes Obesity and Metabolism · 2026
Early Treatment Trajectory and Long‐Term Persistence to Semaglutide for Obesity: A Population‐Based Cohort StudyDiabetes Obesity and Metabolism · 2026

More from Diabetes Obesity and Metabolism

More from Eli Lilly (Japan)

More from Osaka Metropolitan University